Skip to main content
. 2017 Jun 7;9(2):21. doi: 10.3390/pharmaceutics9020021

Figure 5.

Figure 5

Cell viability of MCF7 after 48 h of treatment with gemcitabine-loaded CA and surface modified, gemcitabine-loaded CA. Surface-modified CA denotes the particles modified with streptavidin–biotin–PEG and fibronectin. Values were significant (*) at p value 0.01 to 0.05 and very significant (**) at p value 0.001 to 0.01.